USANA Health Sciences insider Jim Brown nets 1,218 shares after tax
Rhea-AI Filing Summary
USANA Health Sciences (USNA) – Form 4 filing
On 24-Jul-2025, CEO & President Jim Brown converted 2,190 previously granted restricted stock units (code “M”) into an equal number of common shares. To satisfy withholding taxes, 972 of those shares were automatically surrendered to the issuer at $32.09 per share (code “F”). The net effect is an increase of 1,218 directly held shares, bringing Brown’s direct common-stock ownership to 16,934. He also retains 160,878 unvested/derivative RSUs that will convert into common shares as they vest. No open-market purchases or sales occurred; all transactions were internal equity-compensation settlements. The filing does not disclose any broader corporate developments.
Positive
- CEO Jim Brown increased his direct ownership by 1,218 shares, indicating continued alignment with shareholders.
- A substantial pool of 160,878 RSUs remains, tying executive compensation to future share performance.
Negative
- 972 shares were immediately surrendered for tax withholding, reducing the net share increase.
Insights
TL;DR: Routine RSU vesting; CEO nets 1,218 shares, overall impact neutral.
The transaction reflects a scheduled vesting event rather than discretionary buying or selling. Brown’s gross conversion of 2,190 RSUs and tax withholding of 972 shares is standard practice. His post-transaction holding of 16,934 shares remains small relative to the 160,878 RSUs still outstanding, implying most of his equity upside is tied to future company performance. Because no open-market activity or new grants are involved, dilution and market-signal effects are minimal. From an investor viewpoint the filing is not materially impactful but confirms ongoing insider alignment via equity retention.